Poseida Therapeutics PSTX 深 沪
已收盘 01-08 16:00:00 美东时间
9.50
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.50
- 总市值 9.26亿
- 52周最高 9.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.87
- 委 比 0.00%
- 总股本 9746.67万
- 历史最高 17.62
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.54
- 每 手 1
- 风险率 2.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ikena Oncology, Inmagene Biopharmaceuticals appoint Kristin Yarema, as CEO
Ikena Oncology (NASDAQ:IKNA) and Inmagene Biopharmaceuticals on Wednesday announced the appointment of Kristin Yarema, Ph.D. as chief executive officer of ImageneBio, of the combined company after the...
07-23 21:43
细胞和基因治疗临床试验激增42%！115项研究引领全球创新浪潮
（转自：动脉新医药） 6月19日，国家药监局药品审评中心发布了《中国新药注册临床试验进展年度报告（2024年）》（以下简称《报告》）。《报告》从临床试验登记总体...
06-24 15:36
Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025
PAS-004, a next-generation macrocyclic MEK inhibitor developed by Pasithea Therapeutics, has shown preliminary clinical activity as a monotherapy in heavily pre-treated, refractory solid tumors. Interim Phase 1 study results presented at the 2025 ASCO Annual Meeting highlight stable disease in 10 out of 16 efficacy evaluable patients, with tumor reductions and prolonged survival. Notably, a patient with stage 4 BRAF-mutated melanoma achieved a 14...
06-02 12:02
Roche gets FDA clearance for STI test panels
Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S....
01-23 01:40
JPM2025 Day2 | 默沙东计划推出20款重磅炸弹、罗氏继续寻找中国资产、礼来GLP-1不及预期……制药巨头更新业务战略
1月13日，第43届摩根大通医疗保健会议（JP Morgan Healthcare Conference）如期召开。昨天，医药魔方已经报道了强生、BMS、吉利德...
01-15 14:24
Poseida Therapeutics Undergoes Merger and Delisting Changes
Poseida Therapeutics ( ($PSTX) ) has provided an update. Poseida Therapeutics h...
01-08 22:18
罗氏计划完成对美国生物制药公司Poseida的收购
格隆汇1月8日｜罗氏周三表示，计划完成对美国生物制药公司Poseida Therapeutics的收购，交易对价约15亿美元。此次收购于去年11月宣布，是罗氏为...
01-08 15:58
罗氏(RHHBY.US)将完成15亿美元收购美国生物制药公司Poseida(PSTX.US)
罗氏周三表示，计划完成对美国生物制药公司Poseida Therapeutics的收购。
01-08 15:52
Roche to close $1.5B acquisition of Poseida Therapeutics
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will finalize the acquisition of Poseida Therapeutics (NASDAQ:PSTX), a biopharmaceutical company specializing in complex immune cell therapies to treat several types ...
01-08 15:43
Momentum reigned 2024: Buy-rated U.S. stocks with the highest RSI
Momentum was the best trading factor group in 2024, up 19%, according to BofA Securities. Below are buy-rated U.S. stocks by SA Quant Metrics (with Quant ratings of at least 4.5) and the highest relat...
01-04 02:28
